about
Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targetsAnti-α4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infectionEpitopes in α8β1 and other RGD-binding integrins delineate classes of integrin-blocking antibodies and major binding loops in α subunitsLigand-induced Epitope Masking: DISSOCIATION OF INTEGRIN α5β1-FIBRONECTIN COMPLEXES ONLY BY MONOCLONAL ANTIBODIES WITH AN ALLOSTERIC MODE OF ACTION.Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis.Metal ion and ligand binding of integrin α5β1Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor.Anti-α4 Integrin Antibody Blocks Monocyte/Macrophage Traffic to the Heart and Decreases Cardiac Pathology in a SIV Infection Model of AIDS.Structural determinants of integrin β-subunit specificity for latent TGF-β.New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.Role of integrin alpha4 in drug resistance of leukemiaPathway-based approaches to the treatment of inflammatory bowel disease.Infection risk with biologic therapy in patients with inflammatory bowel disease.Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin.Macrophage Polarization in AIDS: Dynamic Interface between Anti-Viral and Anti-Inflammatory Macrophages during Acute and Chronic Infection.The Role of Integrin Expressing Cells in Modulating Disease Susceptibility and Progression (January 2016).Integrins as Therapeutic Targets: Successes and Cancers.Canonical structures of short CDR-L3 in antibodiesSystematic screening of soluble expression of antibody fragments in the cytoplasm of E. coli.Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant.Complementarity determining regions and frameworks contribute to the disulfide bond independent folding of intrinsically stable scFv.Energy landscape differences among integrins establish the framework for understanding activation.Modeling Multiple Myeloma-Bone Marrow interactions and response to drugs in a 3D surrogate microenvironment.Identification of Peptide Mimotope Ligands for Natalizumab
P2860
Q26752806-93D27C71-D775-488D-AF43-5A58B3E2DA67Q27322602-6A859921-5842-4584-BDF9-4F55F2D676FFQ28607846-E0C0981B-0964-4C13-9588-E548A3AAE16AQ30826108-59B7DAD6-AEDA-4CA7-93D8-26BE4E33D3C1Q33759830-D129F407-F0CC-4B0B-9DC0-48BDB4CD8E44Q34753116-ED868F82-545E-405B-BAD2-4081B4D985A7Q35857404-E5906EBF-F240-4C72-8C73-843D19C55D1CQ36168754-06398D34-672F-4ED2-AF23-450598484605Q36476329-93FEBAAF-90FD-442B-83FC-2E604C985B6CQ37045253-C080B401-1BF7-45FC-AF2B-C8CCC38832FAQ38218126-8F31F40F-DFA6-44E3-A7BC-2243CA1D8E24Q38593257-0D0CF351-E670-4A37-870D-624EBC0068C7Q39429997-134C24E3-12B9-4987-AF0D-7E6466E9449EQ40174150-D38E14F0-8930-4EBE-AD1E-DFFF91351C11Q40937611-B2BA85FB-D342-4214-A693-6F88E2EFEB91Q41184465-17FE81DA-3DD5-4298-A6A8-A1046DD17D16Q41670949-8FC67475-4B7F-4A74-B452-FE3DC69A5A7FQ41946585-E7E5E117-CD16-4705-B85F-296AA738F9EFQ42694844-ADE2D295-2C69-4961-ADD1-53B6B4DA4027Q47105347-66EF7C29-3A97-4F62-812C-5DED537B4426Q47158894-A37B3AAD-157D-4DCD-8774-9623663F6B52Q48049356-DD9AF102-BFEA-47A5-B5C2-AA54A761DC94Q50078388-9A8827D1-4575-47A3-B1C9-ED77F8EDD218Q56876832-2059C57E-691B-47BC-9F71-D184005358FE
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
How Natalizumab Binds and Antagonizes 4 Integrins
@ast
How Natalizumab Binds and Antagonizes 4 Integrins
@en
How Natalizumab Binds and Antagonizes 4 Integrins
@nl
type
label
How Natalizumab Binds and Antagonizes 4 Integrins
@ast
How Natalizumab Binds and Antagonizes 4 Integrins
@en
How Natalizumab Binds and Antagonizes 4 Integrins
@nl
prefLabel
How Natalizumab Binds and Antagonizes 4 Integrins
@ast
How Natalizumab Binds and Antagonizes 4 Integrins
@en
How Natalizumab Binds and Antagonizes 4 Integrins
@nl
P2093
P2860
P3181
P356
P1476
How Natalizumab Binds and Antagonizes 4 Integrins
@en
P2093
Thomas Schürpf
Timothy A Springer
P2860
P304
P3181
P356
10.1074/JBC.M113.501668
P407
P577
2013-11-08T00:00:00Z